Abstract
Buprenorphine maintenance treatment has become a major intervention in the care and treatment of drug dependence in Europe. Still little is known about sexual behaviour and sexual dysfunction especially under buprenorphine or methadone maintenance treatment. Our study aimed to evaluate patterns of sexual behaviour and dysfunction prevalence within buprenorphine and methadone maintenance treatment. Significant differences between both groups could be observed regarding sexual excitation disturbances and ability to orgasm. 33.3% of the methadone-maintained group showed significantly higher sexual excitation disturbances (p = 0.006). Future studies of sexual dysfunction in opioid-treated persons should examine the potential benefits of dose reduction, androgen replacement, and choice of opioid.
Keywords: Substituion, Methadone, Buprenorphine, Sexuality, Dysfunction prevalence
Letters in Drug Design & Discovery
Title: Buprenorphine and Methadone Maintenance Treatment - Sexual Behaviour and Dysfunction Prevalence
Volume: 6 Issue: 1
Author(s): S. M. Giacomuzzi, A. Khreis, Y. Riemer, K. Garber and M. Ertl
Affiliation:
Keywords: Substituion, Methadone, Buprenorphine, Sexuality, Dysfunction prevalence
Abstract: Buprenorphine maintenance treatment has become a major intervention in the care and treatment of drug dependence in Europe. Still little is known about sexual behaviour and sexual dysfunction especially under buprenorphine or methadone maintenance treatment. Our study aimed to evaluate patterns of sexual behaviour and dysfunction prevalence within buprenorphine and methadone maintenance treatment. Significant differences between both groups could be observed regarding sexual excitation disturbances and ability to orgasm. 33.3% of the methadone-maintained group showed significantly higher sexual excitation disturbances (p = 0.006). Future studies of sexual dysfunction in opioid-treated persons should examine the potential benefits of dose reduction, androgen replacement, and choice of opioid.
Export Options
About this article
Cite this article as:
Giacomuzzi M. S., Khreis A., Riemer Y., Garber K. and Ertl M., Buprenorphine and Methadone Maintenance Treatment - Sexual Behaviour and Dysfunction Prevalence, Letters in Drug Design & Discovery 2009; 6 (1) . https://dx.doi.org/10.2174/157018009787158580
DOI https://dx.doi.org/10.2174/157018009787158580 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteomic analysis of a <i>hom</i>-disrupted, cephamycin C overproducing <i>Streptomyces clavuligerus</i>
Protein & Peptide Letters Promoted Selective Synthesis of Benzylpyrazolocoumarins Using Silica Sodium Carbonate (SSC): A Novel Green Synthetic Technology Using SSC as a Highly Efficient and Environmentally Safe Catalyst
Current Green Chemistry Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry The Implications of Iodine and its Supplementation During Pregnancy in Fetal Brain Development
Current Clinical Pharmacology Transcranial Direct Current Stimulation for Treatment of Auditory Hallucination: A Systematic Review of Clinical Efficacy
Current Psychiatry Reviews Activation of Brain Endothelium by Soluble Aggregates of the Amyloid-β Protein Involves Nuclear Factor-κB
Current Alzheimer Research Compensatory Shift of Subcallosal Area and Paraterminal Gyrus White Matter Parameters on DTI in Patients with Alzheimer Disease
Current Alzheimer Research Subject Index Volume 6
Mini-Reviews in Medicinal Chemistry Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic
Current Rheumatology Reviews Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer’s Disease
Current Pharmaceutical Design Population Studies of Association Between Lithium and Risk of Neurodegenerative Disorders
Current Alzheimer Research Animal Galectins and Plant Lectins as Tools for Studies in Neurosciences
Current Neuropharmacology Glycolipids as Immune Modulatory Tools
Mini-Reviews in Medicinal Chemistry The Serum Protein and Lipid Oxidation Marker Levels in Alzheimers Disease and Effects of Cholinesterase Inhibitors and Antipsychotic Drugs Therapy
Current Alzheimer Research Effect on Acetylcholinesterase and Anti-oxidant Activity of Synthetic Chalcones having a Good Predicted Pharmacokinetic Profile
Medicinal Chemistry Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine Cyclic ADP-ribose (cADPR) and Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP): Novel Regulators of Ca 2+-Signaling and Cell Function
Current Molecular Medicine The role of vitamin D towards immune tolerance in white adipose tissue (WAT)
Endocrine, Metabolic & Immune Disorders - Drug Targets Identification of Electrophysiological Changes in Alzheimer's Disease: A Microarray Based Transcriptomics and Molecular Pathway Analysis Study
CNS & Neurological Disorders - Drug Targets Choice of Treatment with Antidepressants: Influencing Factors
Current Pharmaceutical Design